What to Expect from Treatment

How soon will I see results with SOLARAZE® Gel?

Your treatment period will probably last between 60 and 90 days, depending on the extent of your lesions and your doctor's recommendation. Results are different for everyone. For example, some people may see results as early as 30 days, while others may not see best results until 30 days after finishing the treatment.

Why is it important to keep using SOLARAZE® Gel even if my AKs are better?

SOLARAZE® Gel continues to work beneath the skin's surface to treat the AKs you can't see yet. That's why it's very important to finish the full course of treatment even if you see results before the end of your prescribed treatment period.

What are the most common side effects?

SOLARAZE® Gel is shown to be well-tolerated by most people; however, some people may experience itching, redness, irritation, rash, dryness, scaling or peeling on the areas treated for AKs.

Most reactions to SOLARAZE® Gel are mild to moderate and go away after you finish the treatment.

Is there anybody who should not use SOLARAZE® Gel?

You should not use SOLARAZE® Gel if you are allergic to this medicine or anything contained within it.

Talk to your doctor before using SOLARAZE® Gel if you:

  • Have a condition involving the combination of asthma, nasal polyps and problems taking aspirin
  • Currently use other NSAIDs, such as aspirin, ibuprofen or naproxen sodium
  • Have ulcers, stomach bleeding or kidney problems
  • Are pregnant or nursing

Important Product Safety Information

SOLARAZE® (diclofenac sodium-3%) Gel is indicated for the topical treatment of actinic keratoses (AKs).

Sun avoidance is indicated during SOLARAZE® Gel therapy. The safety of using sunscreens, cosmetics or topical medications while being treated with SOLARAZE® Gel is not known. Do not get SOLARAZE® Gel into eyes.

As with other non-steroidal anti-inflammatory drugs (NSAIDs), severe allergic reactions may occur in patients without prior exposure to diclofenac. Patients who are allergic or sensitive to aspirin and/or other NSAIDs, who also have asthma and nasal polyps, may have a condition known as the aspirin triad and should tell their doctor before beginning therapy.

SOLARAZE® Gel should be used with caution in patients with active stomach ulcers or bleeding and severe kidney or liver impairments. SOLARAZE® Gel should not be applied to open wounds, skin infections or any skin that shows signs of irritation.

In clinical trials, the most common adverse reactions involved the skin and included contact dermatitis, rash, dry skin and exfoliation (widespread reddened and peeling skin).

SOLARAZE® (diclofenac sodium-3%) Gel Full Prescribing Information.